Treatment with anti-TNF-α significantly mitigates the severity of arthritis and pneumonitis in the collagen antibody-injected and ICI-treated humanized BALB/c-hPD1/hCTLA4 mice. The gene discussed is TNF; the disease is arthritic joint disease.